Related Experiment Video

Updated: Aug 19, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Systemic therapy of melanoma

J M Kirkwood1

  • 1Division of Medical Oncology, University of Pittsburgh Medical Center, PA 15213-2582.

Current Opinion in Oncology
|March 1, 1994
PubMed

Insights

Systemic treatment for melanoma is challenging. New research in melanoma biology and immunology offers hope for evolving therapies and potential prevention strategies.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Systemic treatment of melanoma presents significant challenges for oncologists.
  • Recent advancements in understanding melanoma's molecular biology and immunology have been substantial.
  • The pursuit of agents modulating antitumor activity is yielding new therapeutic insights.

Purpose of the Study:

  • To review recent progress in melanoma treatment.
  • To highlight the evolution of therapy for metastatic melanoma.
  • To discuss the translation of advanced treatment findings to adjuvant settings and prevention.

Main Methods:

  • Review of recent scientific literature on melanoma treatment.
  • Analysis of new therapeutic agents and their impact on antitumor activity.
  • Evaluation of findings from interferon-alpha in the adjuvant setting.

Main Results:

  • Significant progress in understanding melanoma biology and immunology.
  • Emerging information on agents modulating antitumor activity.
  • Promising results from interferon-alpha in the adjuvant treatment of advanced melanoma.

Conclusions:

  • The standard of therapy for metastatic melanoma is expected to evolve.
  • Advances in treating advanced melanoma show promise in the adjuvant setting.
  • Future applications may include melanoma prevention based on precursor biology.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.